Purchase Order 75N90018P00478
- Not listed
- This federal contract award, with an ID of 75N90019P00314, is a purchase order for $20,437.06 awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride), to the National Institutes of Health...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $22,659.68 firm fixed-price purchase order is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, and others, to support nuclear medicine, oncology, and diagnostic imaging services at NIH facilities. Cardinal Health 414 is a major supplier of radiopharmaceuticals and related...
- This federal contract award is to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract, valued at $21,664.10, is a firm fixed-price purchase order issued by the National Institutes of Health (NIH) Clinical Center. It is not set aside for any specific business designation. The contract is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and...
- This is a $22,093.85 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at NIH facilities. Cardinal Health 414 provides both scheduled...
- This $22,829.59 firm fixed-price federal contract was awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of a variety of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $3,835.00, is a firm fixed-price purchase order for various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67. The products will be used to support nuclear...
- This is a $22,733.47 firm fixed-price purchase order awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the National Institutes of Health (NIH) Clinical Center. The contract is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at NIH research centers. Cardinal Health 414 also provides...
- This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The $7,957 Firm Fixed Price Delivery Order contract is for the supply of various radiopharmaceuticals and related products to support nuclear medicine, oncology, and diagnostic imaging services at NIH facilities. Cardinal Health 414 is a major supplier of radiopharmaceuticals to federal agencies,...
- This federal contract award is for the delivery of radiopharmaceuticals, radioactive isotopes, diagnostic imaging agents, and specialty pharmaceuticals to the National Institutes of Health (NIH) Clinical Center. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract has a ceiling value of $25,506.00 and is a delivery order contract with a firm fixed price pricing type. It does not have a set-aside...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The $6,235.00 purchase order is for the delivery of 82 units of a radiopharmaceutical product at a unit price of $75.00. The contract has no set-aside designation and is part of Cardinal Health 414's ongoing work supporting federal nuclear...
This federal contract award, with ID 75N90018P00478, was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The $24,587.55 firm-fixed-price purchase order is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at NIH research centers. Cardinal Health 414 holds numerous Indefinite Delivery Vehicles (IDVs) with federal agencies, particularly the Department of Veterans Affairs (VA), to provide a reliable supply of radiopharmaceuticals and related products. The company's federal contracts often involve daily deliveries, quality control testing, regulatory compliance, and consultation services to support the medical imaging needs of government healthcare facilities. This specific award is not designated as a set-aside contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($315) | 9/12/24 | |
| Not listed | Not listed | $24.9k | 5/24/18 |